By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – As part of a new $13.7 million funding round, the Muscular Dystrophy Association has awarded grants to several research groups that will use genomics and genetics-based science to investigate the molecular causes of neuromuscular diseases.

The new funding will support a total of 40 researchers studying Duchenne muscular dystrophy (DMD), ALS/Lou Gehrig's disease, muscular atrophy, facioscapulohumeral muscular dystrophy, and links between diabetes and Freidreich's ataxia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.